Co-Founder of InPlanta Biotechnologies; Chief Science Advisor at DoseCann
Dr. Darryl Hudson is the Co-founder of InPlanta Biotechnology and VP Science & Innovation for FLOWR corporation. Following his PhD and postdoctoral fellowship in Molecular Biology & Genetics, he worked developing novel commercial fertilizers for agricultural sytemes. After moving on to form a Cannabis company in 2013 under the newly established Canadian framework, Dr. Hudson has since worked as a consultant for projects all over the world. He continues to utilize his expertise to optimize both industrial hemp and medical Cannabis genetics, cultivation and quality assurance protocols. Dr. Hudson has helped develop SOP’s and QA standards for all aspects of Cannabis production including cultivation, extraction, formulation and analytical testing. Through his work in the Cannabis industry, Dr. Hudson has become involved with the treatment of Post-Traumatic Stress (PTSD), specifically in military veterans. This includes breeding Cannabis varieties specifically developed to alleviate the symptoms of PTSD as well as other diseases. He remains an advocate for quality, affordable medicine produced from the Cannabis plant while also overseeing hundreds of acres of industrial hemp cultivation for food and fiber.